
Metoright 25mg Tablet ER
Marketer
Gold Line
Salt Composition
Metoprolol Succinate (25mg)
Overview Metoright 25mg Tablet ER
CardioBeta 25mg Extended-Release Tablets are classified as beta-blockers, employed in managing hypertension, angina pectoris (chest discomfort stemming from heart issues), and cardiac arrhythmias. This medication also aids in migraine prevention and reduces the risk of future strokes and myocardial infarctions. CardioBeta 25mg ER may be administered independently or concurrently with other pharmaceuticals. Dosage and frequency are tailored to the specific condition and its severity. Consumption may occur with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic effects might not be evident for several weeks; long-term use may be necessary. Continued use is vital even with symptom absence, as discontinuation can exacerbate underlying conditions. Common, typically transient, side effects include fatigue, cephalalgia, depressive symptoms, diarrhea, skin rashes, bradycardia, dizziness, and nausea. Less frequent adverse reactions include dyspnea and hypotension. Gradual dose escalation minimizes side effects. Consult your physician regarding persistent or bothersome adverse events. Prior to commencing treatment, disclose any hepatic impairment. CardioBeta 25mg ER is contraindicated in individuals with bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Pregnant or lactating women require medical consultation before initiation. Individual suitability must be determined by a physician through a thorough assessment. Regular blood pressure monitoring ensures treatment effectiveness. Alcohol consumption should be avoided due to potential exacerbation of certain side effects.
Primary Ingredients of Metoright 25mg Tablet ER
The provided text is "undefined," which lacks meaning and cannot be rephrased. There is no text to rewrite.
Uses of Metoright 25mg Tablet ER
Managing angina pectoris (chest pain stemming from heart conditions) | Correcting cardiac arrhythmias | Reducing the risk of myocardial infarction | Controlling hypertension (elevated blood pressure) | Preventing migraine headaches
Major Benefits of Metoright 25mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Metoright 25mg Extended-Release tablet whole; do not crush, chew, or break it. This medication can be taken with or without food, but consistency in timing is recommended. For optimal absorption, avoid consuming Metoright 25mg Tablet ER with meals high in fat, including items like olive oil, nuts (especially Brazil nuts), dark chocolate, butter, and red meat.
Common Side effects of Metoright 25mg Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metoright 25mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Metoright 25mg Extended-Release tablet whole; do not crush, chew, or break it. This medication can be taken with or without food, but consistency in timing is recommended. Minimize consumption of high-fat foods, including olive oil, nuts (especially Brazil nuts), dark chocolate, butter, and fatty meats, while taking Metoright 25mg Tablet ER.
How Metoright 25mg Tablet ER works:
CardioMet 25mg Extended-Release tablets are a sustained-release beta-adrenergic blocker with cardioselective action. This medication reduces heart rate and enhances the heart's pumping efficiency, improving systemic circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metoright 25mg Extended-Release tablets and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Metoright 25mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metoright 25mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with the medication.
DrivingUNSAFE
Extended-release Metoright 25mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects are experienced.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Metoright 25mg Extended-Release tablets without requiring any dosage modification.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Metoright 25mg Extended-Release tablets. Dosage modification of Metoright 25mg Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Metoright 25mg Tablet ER :
Should you forget a Metoright 25mg Extended-Release Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metoright 25mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |
